XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)
$0 None (None%)
Analysed XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) News Sources
Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO's Heart Technology Presented at ISHLT in Toronto
22-04-2026
yahoo.com
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation
22-04-2026
yahoo.com
Interim Report January - March 2026
24-04-2026
yahoo.com
Xvivo Perfusion AB (XVIPF) Q1 2026 Earnings Call Highlights: Strong Organic Growth and Positive ...
25-04-2026
yahoo.com
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
27-04-2026
yahoo.com
Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO's Heart Technology
18-05-2026
yahoo.com
Exploring European Undervalued Small Caps With Insider Action In June 2026
11-06-2026
yahoo.com
Conference call on Interim Report April-June 2026
26-06-2026
yahoo.com
Interim Report January - June 2026
14-07-2026
yahoo.com
Xvivo Perfusion AB (XVIPF) Q2 2026 Earnings Call Highlights: Strong Organic Growth Amidst ...
14-07-2026
yahoo.com
What is the current price of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)?
The current price of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) is $0.
XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) since the previous trading day is $None.
XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)?
The most recent average sentiment score for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) is 58 out of 100.
What is the most recent average sentiment for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)?
The most recent sentiment for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) is .
SEC-8K** Filing Available For XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.